Literature DB >> 32086362

Quality indicators for advanced ovarian cancer surgery from the European Society of Gynaecological Oncology (ESGO): 2020 update.

Christina Fotopoulou1, Nicole Concin2, François Planchamp3, Philippe Morice4, Ignace Vergote5,6, Andreas du Bois7, Denis Querleu8.   

Abstract

Entities:  

Keywords:  ovarian cancer; surgical oncology

Mesh：

Year:  2020        PMID： 32086362     DOI： 10.1136/ijgc-2020-001248

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN： 1048-891X            Impact factor:   3.437


× No keyword cloud information.
  10 in total

1.  Rectosigmoid resection by gynecologic oncologists versus colorectal surgeons: as long as it catches the mouse, does the color of the cat matter?

Authors:  Suk Joon Chang; Christina Fotopoulou; Robert E Bristow; Dennis S Chi; William A Cliby
Journal:  J Gynecol Oncol       Date:  2021-05       Impact factor: 4.401

2.  Machine Learning-Based Risk Prediction of Critical Care Unit Admission for Advanced Stage High Grade Serous Ovarian Cancer Patients Undergoing Cytoreductive Surgery: The Leeds-Natal Score.

Authors:  Alexandros Laios; Raissa Vanessa De Oliveira Silva; Daniel Lucas Dantas De Freitas; Yong Sheng Tan; Gwendolyn Saalmink; Albina Zubayraeva; Racheal Johnson; Angelika Kaufmann; Mohammed Otify; Richard Hutson; Amudha Thangavelu; Tim Broadhead; David Nugent; Georgios Theophilou; Kassio Michell Gomes de Lima; Diederick De Jong
Journal:  J Clin Med       Date:  2021-12-24       Impact factor: 4.241

3.  Assessment of ESGO Quality Indicators in Cervical Cancer Surgery: A Real-World Study in a High-Volume Chinese Hospital.

Authors:  Yan Ding; Xuyin Zhang; Junjun Qiu; Jianfeng Zhang; Keqin Hua
Journal:  Front Oncol       Date:  2022-01-25       Impact factor: 6.244

Review 4.  Insights into ovarian cancer care: report from the ANZGOG Ovarian Cancer Webinar Series 2020.

Authors:  Andreas Obermair; Philip Beale; Clare L Scott; Victoria Beshay; Ganessan Kichenadasse; Bryony Simcock; James Nicklin; Yeh Chen Lee; Paul Cohen; Tarek Meniawy
Journal:  J Gynecol Oncol       Date:  2021-11       Impact factor: 4.401

Review 5.  Novel Ex Vivo Models of Epithelial Ovarian Cancer: The Future of Biomarker and Therapeutic Research.

Authors:  James Clark; Christina Fotopoulou; Paula Cunnea; Jonathan Krell
Journal:  Front Oncol       Date:  2022-03-25       Impact factor: 6.244

6.  Explainable Artificial Intelligence for Prediction of Complete Surgical Cytoreduction in Advanced-Stage Epithelial Ovarian Cancer.

Authors:  Alexandros Laios; Evangelos Kalampokis; Racheal Johnson; Amudha Thangavelu; Constantine Tarabanis; David Nugent; Diederick De Jong
Journal:  J Pers Med       Date:  2022-04-10

7.  Factors Predicting Surgical Effort Using Explainable Artificial Intelligence in Advanced Stage Epithelial Ovarian Cancer.

Authors:  Alexandros Laios; Evangelos Kalampokis; Racheal Johnson; Sarika Munot; Amudha Thangavelu; Richard Hutson; Tim Broadhead; Georgios Theophilou; Chris Leach; David Nugent; Diederick De Jong
Journal:  Cancers (Basel)       Date:  2022-07-15       Impact factor: 6.575

8.  Evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients: a survey from MITO-MaNGO Groups.

Authors:  Stefano Greggi; Francesca Falcone; Giovanni D Aletti; Marco Cascella; Francesca Bifulco; Nicoletta Colombo; Sandro Pignata
Journal:  J Gynecol Oncol       Date:  2022-06-03       Impact factor: 4.756

9.  Primary Treatment Results in Patients with Ovarian, Fallopian or Peritoneal Cancer-Results of a Clinical Cancer Registry Database Analysis in Germany.

Authors:  Robert Armbrust; Peter Ledwon; Anne Von Rüsten; Constanze Schneider; Jalid Sehouli
Journal:  Cancers (Basel)       Date:  2022-09-24       Impact factor: 6.575

10.  Feature Selection is Critical for 2-Year Prognosis in Advanced Stage High Grade Serous Ovarian Cancer by Using Machine Learning.

Authors:  Alexandros Laios; Angeliki Katsenou; Yong Sheng Tan; Racheal Johnson; Mohamed Otify; Angelika Kaufmann; Sarika Munot; Amudha Thangavelu; Richard Hutson; Tim Broadhead; Georgios Theophilou; David Nugent; Diederick De Jong
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.